Antigen specificity and localization may indeed be critical components of CD8+ T-cell vaccine designs as a cohort of TB-infected individuals from the Gambia showed reduced CD8+ T-cell activation and cytotoxicity by flow cytometry after stimulation with Mtb H37Rv compared to healthy BCG-vaccinated controls (326). Here, CD8A is linked to tuberculosis.